Malignant Endocrine Neoplasm — Trials

Malignant Endocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,801 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 576
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +2.2%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (238)

clinicaltrialsPublishedShowing 1–30 of 30 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07458906	DLL3-Targeted PET/CT in Neuroendocrine Carcinoma	recruiting	N/A	80	The First Affiliated Hospital of Xiamen UniversityOTHER	1	Sep 25, 2026	clinicaltrials
NCT04342429	Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer	recruiting	N/A	30	Emory UniversityOTHER	1	Sep 17, 2026	clinicaltrials